{"disease":{"id":"schizophreniform-disorder","name":"schizophreniform disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03201757","title":"Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":523,"lead_sponsor_name":"Alkermes, Inc.","has_results":true},{"nct_id":"NCT05658510","title":"Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":false},{"nct_id":"NCT03187769","title":"Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":426,"lead_sponsor_name":"Alkermes, Inc.","has_results":true},{"nct_id":"NCT04268303","title":"Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT03559426","title":"Research Into Antipsychotic Discontinuation and Reduction Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":253,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT03848234","title":"Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":209,"lead_sponsor_name":"Tangent Data","has_results":false},{"nct_id":"NCT05877716","title":"EPI-MINN: Targeting Cognition and Motivation - National","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT04298450","title":"ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT04113993","title":"Bazedoxifene -Treatment for Women With Schizophrenia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"The Alfred","has_results":false},{"nct_id":"NCT06423651","title":"Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Universitat Autonoma de Barcelona","has_results":false},{"nct_id":"NCT05538832","title":"Remote State Representation in Early Psychosis","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT04004416","title":"Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT05025605","title":"Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":false},{"nct_id":"NCT03974620","title":"Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Pakistan Institute of Living and Learning","has_results":false},{"nct_id":"NCT05416658","title":"Shared Decision Making for Antipsychotic Medications","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"New York State Psychiatric Institute","has_results":false},{"nct_id":"NCT02823041","title":"Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04093518","title":"Estradiol as add-on to Antipsychotics","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Tangent Data","has_results":false},{"nct_id":"NCT03919760","title":"Early Psychosis Intervention - Spreading Evidence-based Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT05890183","title":"Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04013555","title":"The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":true},{"nct_id":"NCT04673851","title":"Horyzons: Implementation in Clinical Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT04497857","title":"Academic-Community EPINET (AC-EPINET)","phase":"NA","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT04418011","title":"Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT05784948","title":"Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Chonbuk National University Hospital","has_results":false},{"nct_id":"NCT03510741","title":"Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Pakistan Institute of Living and Learning","has_results":false},{"nct_id":"NCT02787122","title":"Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia","phase":"NA","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Philipps University Marburg","has_results":false},{"nct_id":"NCT05109065","title":"Peripheral Immune System in Individuals With Schizophrenia","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT02533232","title":"Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Pakistan Institute of Living and Learning","has_results":false},{"nct_id":"NCT03632278","title":"Mindfulness Psychoeducation Program for Schizophrenia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":58,"lead_sponsor_name":"The Hong Kong Polytechnic University","has_results":false},{"nct_id":"NCT06002958","title":"Horyzons: Implementation and Integration in Clinical Practice","phase":"NA","overall_status":"TERMINATED","enrollment_count":52,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT02212041","title":"Electronic Cigarettes in Smokers With Mental Illness","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT04173572","title":"Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT03079024","title":"Minnesota Community-Based Cognitive Training in Early Psychosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"University of Minnesota","has_results":true},{"nct_id":"NCT03067311","title":"Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT02566057","title":"Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT07116694","title":"Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":false},{"nct_id":"NCT07006935","title":"REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Case Western Reserve University","has_results":false},{"nct_id":"NCT06041646","title":"Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT07263022","title":"Cognitive Strategies in Early Psychosis 2","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT03757988","title":"Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT05756855","title":"Young Adults With Violent Behavior During Early Psychosis (Aim 2)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT04203056","title":"Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"University of California, Los Angeles","has_results":true},{"nct_id":"NCT05974527","title":"Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false}],"total":43},"guidelines":[],"source":"Drug Landscape verified database"}